Therefore, in this study we assessed (i) plasma concentrations of PON-1, PSH, and MDA in RA compared with controls, and (ii) the relationship of these biomarkers with peripheral vasodilatory capacity and the presence of peripheral ED in RA patients. The gene discussed is PON1; the disease is rheumatoid arthritis.